{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:37:07Z","timestamp":1790915827114,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.pnpbp.2006.04.003","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T22:52:09Z","timestamp":1152226329000},"page":"1261-1264","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy of olanzapine and haloperidol in an animal model of mania"],"prefix":"10.1016","volume":"30","author":[{"given":"Rif S.","family":"El-Mallakh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary O'Malley","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Adnan","family":"El-Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.04.003_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine: pharmacokinetics, pharmacodynamics, and clinical trial profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0167-0115(88)90062-6","article-title":"Des\u2013Leu angiotensin I: biosynthesis and drinking response","volume":"20","author":"Changaris","year":"1988","journal-title":"Regul Pept"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib3","first-page":"62P","article-title":"The effect of lithium on the hypermotility response to the central administration of ouabain in the rat","volume":"118","author":"Cooper","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0278-5846(99)00111-6","article-title":"Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model of bipolar illness","volume":"24","author":"Decker","year":"2000","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0278-5846(95)00123-D","article-title":"An animal model for mania: preliminary results","volume":"19","author":"El-Mallakh","year":"1995","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1034\/j.1399-5618.2003.00053.x","article-title":"Intracerebroventricular administration of ouabain to rats models mania","volume":"5","author":"El-Mallakh","year":"2003","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002130050592","article-title":"Chronic haloperidol produces a time- and dose-related slowing of lick rhythm in rats: implications for rodent models of tardive dyskinesia and neuroleptic-induced parkinsonism","volume":"137","author":"Fowler","year":"1998","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.biopsych.2005.04.008","article-title":"Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa?","volume":"58","author":"Hillebrand","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3940(91)90725-9","article-title":"Chronic haloperidol treatment attenuates receptor-mediated phosphoinositide turnover in rat brain slices","volume":"129","author":"Li","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0091-3057(93)90360-6","article-title":"Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain","volume":"46","author":"Li","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1520-6394(1997)5:2<53::AID-DA1>3.0.CO;2-6","article-title":"Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness","volume":"5","author":"Looney","year":"1997","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib13","first-page":"268","article-title":"Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity","volume":"109","author":"Lorene-Koci","year":"1996","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib14","first-page":"142","article-title":"A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"57","author":"McElroy","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/j.1440-1614.2005.01649.x","article-title":"Maintenance therapies in bipolar disorder: focus on randomized controlled trials","volume":"39","author":"Muzina","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib16","series-title":"Olanzapine (Zyprexa) \u2014 a novel antipsychotic","first-page":"217","article-title":"Disposition and biotransformation of olanzapine in animals and humans","author":"Potts","year":"2000"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0006-3223(97)00440-X","article-title":"Alpha2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals","volume":"44","author":"Rose","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-9384(97)00457-5","article-title":"Persistent hyperactivity following a single intracerebroventricular dose of ouabain","volume":"63","author":"Ruktanonchai","year":"1998","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with resperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania","volume":"156","author":"Tohen","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-0327(00)00162-2","article-title":"A meta-analysis of the use of typical antipsychotic agents in bipolar disorder","volume":"65","author":"Tohen","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-flouxetine combination in the traetment of bipolat I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","article-title":"Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial","volume":"162","author":"Tohen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.003_bib23","series-title":"Olanzapine (Zyprexa) \u2014 a novel antipsychotic","first-page":"114","article-title":"Facilitation of NMDA transmission by olanzapine","author":"Wang","year":"2000"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T23:57:45Z","timestamp":1683503865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0278584606001394"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.04.003","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}